Concepedia

Lenny Dang

LD

38

Publications

13.1K

Citations

32

H-Index

2002

Active since

Affiliations

Agios Pharmaceuticals (United States)(Current)

Millennium Engineering and Integration (United States)

National Institutes of Health

Harvard University

National Cancer Institute

Lenny Dang is an author at Agios Pharmaceuticals (United States) specializing in medicine, cancer research, and tumor biology.

Top concepts

MedicineTumor BiologyCancer ResearchCell BiologyCancer BiologyCancer Cell BiologyBiochemistryPharmacologyPathologyCell Death

Publications per year

2002–2022

38

Publications

38

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4K citations · Full text

Tumor Biology, Cancer-associated Idh1 Mutations, Oncogenic Agent +4

Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

Christina M. Annunziata, R. Eric Davis, Yulia N. Demchenko et al. · Cancer Cell · 2007 · 929 citations · Full text

Hematological Malignancy, Tumor Biology, Alternative Nf-κb Pathways +9

NF-κB as a Therapeutic Target in Multiple Myeloma

Teru Hideshima, Dharminder Chauhan, Paul G. Richardson et al. · Journal of Biological Chemistry · 2002 · 891 citations · Full text

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou, Yimin Yu, William J. Israelsen et al. · Nature Chemical Biology · 2012 · 804 citations · Full text

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 789 citations

Rows per page

1–5 of 38